SERUM LEVEL AND PRODUCTION OF CYTOKINES BY PBMC IN PATIENTS WITH ATOPIC DERMATITIS
Abstract
The рарег presents the results of measurements of cytokine levels in serum and conditioned medium of PBMC cultures from the patients with atopic dermatitis with the exacerbation and remission in comparison with the healthy donors. We have shown that the serum levels of the key cytokines IL-5 and IL-13, proinflammatory cytokines IL-1β and IL-6 and the main Th1 cytokine — IFNγ — were higher compared to healthy donors. In the conditioned media of peripheral blood mononuclear cells in contrast, we have found a significant decrease of the spontaneous secretion of key cytokines IL-10 and IL-17. We have shown that the stimulated secretion of IL-5 and IL-13, IL-12 and INF-γ is significantly reduced in comparison with the control level. Only IL-1β revealed a statistically significant higher level of stimulated secretion without exacerbation of atopic dermatitis. The contemporary therapy has no effect on cytokine production.
About the Authors
A. N. Silkov
Research Institute of Clinical Immunology
Russian Federation
Russian Federation
T. V. Kovalevskaya-Kutcheryavenko
Research Institute of Clinical Immunology
Russian Federation
Russian Federation
S. A. Falaleyeva
Research Institute of Clinical Immunology
Russian Federation
Russian Federation
J. A. Shevchenko
Research Institute of Clinical Immunology
Russian Federation
Russian Federation
V. M. Nepomnyaschikh
Research Institute of Clinical Immunology
Russian Federation
Russian Federation
S. V. Sennikov
Research Institute of Clinical Immunology
Russian Federation
Russian Federation
References
1. Атопический дерматит: рек. для практ. врачей. - М.: Фармус Принт, 2002. - 45 с.
2. Загрешенко Д.С., Климов В.В., Денисов А.А. Цитокины «кожного окна» при атопическом дерматите // Бюл. сибир. мед. - 2009. - № 3. - C. 32-36.
3. Brandt E.B., Sivaprasad U. Th2 cytokines and atopic dermatitis // J. Clin. Cell. Immunol. - 2011. -Vol. 10. - P. 23.
4. Cantani A., Micera M. A study on 300 asthmatic children, 300 controls and their parents confirms the genetic transmission of allergy and asthma // Eur. Rev. Med. Pharmacol. Sci. - 2011. -Vol. 15. -P. 1051 -1056.
5. Cork M.J., Danby S.G., Vasilopoulos Y., Hadgraft J. et al. Epidermal Barrier Dysfunction in Atopic Dermatitis // Journal of Investigative Dermatology. - 2009. - Vol. 129. - P. 1892-1908.
6. Gutman-Yassky E., Lowes M.A., Fuentes-Duculan J., Whynot J. et al. Major differences in inflammatory dendritic cells and their products distinguish atopic dermatitis from psoriasis // J. Allergy Clin. Immunol. - 2007. - Vol. 119. - P. 2010-2017.
7. Jung T., Stingl G. Atopic dermatitis: Therapeutic concepts evolving from new pathophysiologic insights // J. Allergy Clin. Immunol. - 2008. -Vol. 122. - P. 1074-1081.
8. Machura E., Mazur B. Intracellular production of il-2, il-4, ifn-gamma, and tnf-alpha by peripheral blood cd3+ and cd4+ t cells in children with atopic dermatitis // Eur J Pediatr. - 2007. - Vol. 166, N 8. - P. 789-795.
9. Novak N., Bieber T., Leung D.Y.M. Immune mechanisms leading to atopic dermatitis // J Allergy Clin Immunol. - 2003. - Vol. 112. - P. 128-139.
10. Spergel J.M. Immunology and Treatment of Atopic Dermatitis // Am. J. Clin. Dermatol. - 2008. -Vol. 9, N 4. - P. 233-234.
11. Williams H., Robertson C., Stewart A. Worldwide variations in the prevalence of symptoms of atopic eczema in the International Study of Asthma and Allergies in Childhood // J. Allergy Clin. Immunol. - 1999. - Vol. 103. - P. 125.
12. Zeppa L., Bellini V., Posted P.L. Atopic dermatitis in adults // J. Dermatitis. - 2011. - Vol. 22. -P. 40-46.
Review
For citations:
Silkov A.N., Kovalevskaya-Kutcheryavenko T.V., Falaleyeva S.A., Shevchenko J.A., Nepomnyaschikh V.M., Sennikov S.V. SERUM LEVEL AND PRODUCTION OF CYTOKINES BY PBMC IN PATIENTS WITH ATOPIC DERMATITIS. Acta Biomedica Scientifica. 2012;(3(2)):175-179. (In Russ.)
Views:
610
.png)
Email this article 
